Literature DB >> 23209177

The role of the tumor microenvironment in regulating angiogenesis.

Randolph S Watnick1.   

Abstract

The tumor-associated stroma has been shown to play a significant role in cancer formation. Paracrine signaling interactions between epithelial tumor cells and stromal cells are a key component in the transformation and proliferation of tumors in several organs. Whereas the intracellular signaling pathways regulating the expression of several pro- and antiangiogenic proteins have been well characterized in human cancer cells, the intercellular signaling that takes place between tumor cells and the surrounding tumor-associated stroma has not been as extensively studied with regard to the regulation of angiogenesis. In this chapter we define the key players in the regulation of angiogenesis and examine how their expression is regulated in the tumor-associated stroma. The resulting analysis is often seemingly paradoxical, underscoring the complexity of intercellular signaling within tumors and the need to better understand the environmental context underlying these signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23209177      PMCID: PMC3543072          DOI: 10.1101/cshperspect.a006676

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  184 in total

Review 1.  Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.

Authors:  Elvira Olaso; Fernando Vidal-Vanaclocha
Journal:  Methods Mol Med       Date:  2003

Review 2.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

Review 3.  The myofibroblast in wound healing and fibrocontractive diseases.

Authors:  G Gabbiani
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

Review 4.  Shaping the immune response to parasites: role of dendritic cells.

Authors:  Alan Sher; Edward Pearce; Paul Kaye
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

5.  Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis.

Authors:  Benjamin T Suratt; Joseph M Petty; Scott K Young; Kenneth C Malcolm; Jonathan G Lieber; Jerry A Nick; Jose-Angel Gonzalo; Peter M Henson; G Scott Worthen
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

6.  Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis.

Authors:  Randolph S Watnick; Yi-Ning Cheng; Annapoorni Rangarajan; Tan A Ince; Robert A Weinberg
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

7.  TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.

Authors:  Takahiko Nakagawa; Jin H Li; Gabriela Garcia; Wei Mu; Ester Piek; Erwin P Böttinger; Yan Chen; Hong J Zhu; Duk-Hee Kang; George F Schreiner; Hui Y Lan; Richard J Johnson
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

8.  Measurement of macromolecular diffusion coefficients in human tumors.

Authors:  Edward B Brown; Yves Boucher; Selim Nasser; Rakesh K Jain
Journal:  Microvasc Res       Date:  2004-05       Impact factor: 3.514

9.  Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol.

Authors:  Krishanu Sengupta; Snigdha Banerjee; Neela K Saxena; Sushanta K Banerjee
Journal:  Mol Cancer Res       Date:  2004-03       Impact factor: 5.852

10.  Regulation of the chemokine receptor CXCR4 by hypoxia.

Authors:  Tiziana Schioppa; Badarch Uranchimeg; Alessandra Saccani; Subhra K Biswas; Andrea Doni; Annamaria Rapisarda; Sergio Bernasconi; Simona Saccani; Manuela Nebuloni; Luca Vago; Alberto Mantovani; Giovanni Melillo; Antonio Sica
Journal:  J Exp Med       Date:  2003-11-03       Impact factor: 14.307

View more
  43 in total

1.  Salvianolic acid A inhibits tumor-associated angiogenesis by blocking GRP78 secretion.

Authors:  Yufei Yang; Lichao Zhang; Xiaoqin La; Zhuoyu Li; Hanqing Li; Songjia Guo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-17       Impact factor: 3.000

Review 2.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

3.  Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: can we use enemy territory at our advantage?

Authors:  Carlo Genova; Erika Rijavec; Francesco Grossi
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  Escape from breast tumor dormancy: The convergence of obesity and menopause.

Authors:  Roopali Roy; Jiang Yang; Takaya Shimura; Lauren Merritt; Justine Alluin; Emily Man; Cassandra Daisy; Rama Aldakhlallah; Deborah Dillon; Susan Pories; Lewis A Chodosh; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

5.  Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes.

Authors:  Halema Al-Farsi; Iman Al-Azwani; Joel A Malek; Lotfi Chouchane; Arash Rafii; Najeeb M Halabi
Journal:  J Transl Med       Date:  2022-05-26       Impact factor: 8.440

Review 6.  The Contribution of Angiogenesis to the Process of Metastasis.

Authors:  Diane R Bielenberg; Bruce R Zetter
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

7.  Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Esther M John; Mariana C Stern; Jennifer Herrick; Abbie Lundgreen; Anna R Giuliano; Lisa Hines; Kathy B Baumgartner; Gabriela Torres-Mejia; Roger K Wolff
Journal:  Breast Cancer Res Treat       Date:  2013-08-03       Impact factor: 4.872

Review 8.  Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment.

Authors:  Mariia Zadorozhna; Sante Di Gioia; Massimo Conese; Domenica Mangieri
Journal:  Mol Biol Rep       Date:  2020-02-10       Impact factor: 2.316

9.  Evidence of Tumour Microenvironment and Stromal Cellular Components in Retinoblastoma.

Authors:  Rajeswari Raguraman; Sowmya Parameswaran; Jagat Rakesh Kanwar; Vikas Khetan; Pukhraj Rishi; Rupinder Kaur Kanwar; Subramanian Krishnakumar
Journal:  Ocul Oncol Pathol       Date:  2018-07-17

10.  KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.

Authors:  Zhaodong Li; Bingxin Yu; Fangyuan Qi; Fan Li
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.